AUSTINLAZ
AUSTINLAZ (AUSTINLAZ) is listed on the Nigerian Exchange in the Healthcare sector, with exposure to Non-operating Establishments. This page brings together the current share price, valuation, dividend context, business summary, and a practical 12-week outlook so you can assess the stock faster.
Healthcare
₦3.67B
N/A
N/A
Current price
₦3.73
Updated Updated 3h ago
12-week outlook signal
P/B
2.68
RSI
43.43
52W high
₦5.94
52W low
₦1.71
Valuation view
Valuation signal is limited
Income view
Income signal not strong yet
Momentum view
Momentum is balanced
Risk view
Lower volatility profile
Business trend
Operating trend signal is thin
AUSTINLAZ is listed in the healthcare sector as a "Non-operating Establishment," which suggests it does not run active healthcare services and mainly holds assets or business interests rather than operating hospitals or clinics. It likely earns money from investment income, asset sales, rents or dividends, or other non-operating sources, but public details about its exact revenue streams are limited.
Investors usually follow AUSTINLAZ for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
No reliable trend metrics available yet.
P/B ratio
2.68
Useful for book value support.
Explain the key numbers
Market cap
₦3.67B
Market cap is the total value of all shares. Bigger caps are often more stable; smaller caps can move faster but carry higher risk.
No recent dividend record in the current dataset.
Estimated earnings date
2026-04-30
Estimated earnings date
2026-04-23
AUSTINLAZ
AUSTINLAZ
Price: ₦3.73
P/E: N/A
Yield: N/A
FIDSON
FIDSON
Price: ₦99.50
P/E: 24.16
Yield: 1.51%
MAYBAKER
MAYBAKER
Price: ₦39.35
P/E: 15.30
Yield: 1.02%
MCNICHOLS
MCNICHOLS
Price: ₦6.06
P/E: 21.28
Yield: 0.61%
Price updated
0d ago
Fundamentals updated
0d ago
Market cap
₦3.67B
Open
₦3.40
Previous close
₦3.40
Day range
₦3.40 – ₦3.73
52-week range
₦1.71 – ₦5.94
Volume
2,178,825
Average volume
968,660
Beta
0.32
RSI
43.43
Book value / share
1.31
At least one liquidity signal is strong now, though large orders should still be staged.
There is no recent dividend record in the current data, which reduces the income case.